학술논문
Significant differences in the decision making process exist between melanoma patients who accept or decline high-dose adjuvant interferon-alpha-2B therapy
Document Type
Abstract
Source
In Journal of the American Academy of Dermatology March 2004 50(3) Supplement:P5-P5
Subject
Language
ISSN
0190-9622